Point72 Asset Management, L.P. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 0 0.000% | -4,401,659 (Position Closed) | Filing |
| 2025-06-04 4:32 pm Purchase | 2025-05-29 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 4,401,659 5.100% | 4,401,659 (New Position) | Filing |